Suchergebnisse - "Otero, Jorge"

PubPharm (4)

1

Prognostic significance of telomerase reverse transcriptase promoter gen mutations in high grade meningiomas

enthalten in: Biomedica : revista del Instituto Nacional de Salud | 2022

von Cañas, A. | Jiménez, E. | Hakim, F. | +29

2

EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP)

enthalten in: JCO precision oncology | 2021

von Cardona, A. | Ordóñez-Reyes, C. | Ruiz-Patiño, A. | +22

3

Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab

enthalten in: Anticancer research | 2017

von Wills, B. | Cardona, A. | Rojas, L. | +14

4

Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer : Outcomes according to Thymidylate Synthase Expression

enthalten in: PloS one | 2016

von Cardona, A. | Rojas, L. | Wills, B. | +11

1
[1]